Search Results - "MCGORY, R"

Safety Profile, Pharmacokinetics, and Pharmacodynamics of Siplizumab, A Humanized Anti-CD2 Monoclonal Antibody, in Renal Allograft Recipients by Pruett, T.L, McGory, R.W, Wright, F.H, Pescovitz, M.D, Yang, H, McClain, J.B

“…Abstract Background We report the safety profile, pharmacokinetics (PK), and pharmacodynamics (PD) of siplizumab, a humanized IgG1 anti-CD2 monoclonal antibody…”
Get full text

Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunization by MCGORY, R. W, ISHITANI, M. B, OLIVEIRA, W. M, STEVENSON, W. C, MCCULLOUGH, C. S, DICKSON, R. C, CALDWELL, S. H, PRUETT, T. L

“…Passive immunization with hepatitis B surface antibody (anti-HBs) is important to prevent hepatitis B virus (HBV) recurrence after orthotopic liver…”
Get full text

Pharmacoeconomic analysis of HBV liver transplant therapies by McGory, R

“…The outcome of liver transplantation for patients infected with the hepatitis B virus (HBV) has greatly improved over the last several years. The rate of…”
Get full text

Pharmacokinetics of vancomycin in patients with various degrees of renal function by MATZKE, G. R, MCGORY, R. W, HALSTENSON, C. E, KEANE, W. F

“…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
Get full text

Improved clinical outcomes with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization by Sawyer, R G, McGory, R W, Gaffey, M J, McCullough, C C, Shephard, B L, Houlgrave, C W, Ryan, T S, Kuhns, M, McNamara, A, Caldwell, S H, Abdulkareem, A, Pruett, T L

“…The goals were to summarize the results of liver transplantation for chronic hepatitis B disease (HBV) at the University of Virginia, correlate pretransplant…”
Get full text

Oral ganciclovir dosing in transplant recipients and dialysis patients based on renal function by PESCOVITZ, M. D, PRUETT, T. L, GONWA, T, BROOK, B, MCGORY, R, WICKER, K, GRIFFY, K, ROBINSON, C. A, JUNG, D

“…An oral formulation of ganciclovir (GCV) was recently approved for the prevention of cytomegalovirus disease in solid organ transplant recipients. This study…”
Get full text

Hepatitis B immune globulin: the US experience by Pruett, T L, McGory, R

“…The increasingly aggressive use of hepatitis B immune globulin (HBIg) in liver transplantation for hepatitis B infected patients has led to a great improvement…”
Get full text

Prostaglandin E1 administration following orthotopic liver transplantation: A randomized prospective multicenter trial by Klein, AS, Cofer, JB, Pruett, TL, Thuluvath, PJ, McGory, R, Uber, L, Stevenson, WC, Baliga, P, Burdick, JF

“…BACKGROUND & AIMS: Prostaglandin E1 (PGE1) has been used after orthotopic liver transplantation (OLT) based on limited clinical data suggesting PGE1 infusion…”
Get full text

Retransplantation of patients with severe posttransplant hepatitis B in the first allograft by ISHITANI, M, MCGORY, R, WRIGHT, T, LARE, J, DICKSON, R, CALDWELL, S, BICKSTON, S, MCCULLOUGH, C, PRUETT, T, TERRAULT, N, ROBERTS, J, ASCHER, N

“…The outcome of orthotopic liver transplantation (OLTX) in patients retransplanted for severe hepatitis B virus (HBV) in the first allograft has been poor due…”
Get full text

Pharmacokinetic considerations by Volles, D F, McGory, R

“…Limited studies of the pharmacokinetics of pain medication suggest altered serum elimination when the liver is hypoperfused or affected by severe cirrhosis…”
Get more information

ORAL GANCICLOVIR DOSING IN TRANSPLANT RECIPIENTS AND DIALYSIS PATIENTS BASED ON RENAL FUNCTION1 by Pescovitz, Mark D., Pruett, Timothy L., Gonwa, Thomas, Brook, Bonnie, McGory, R., Wicker, K., Griffy, Kay, Robinson, Charles A., Jung, Donald

Get full text

Prevention of hepatitis B "rerecurrence" after a second liver transplant--the role of maintenance polyclonal HBIG therapy by Kiyasu, P K, Ishitani, M B, McGory, R W, Gaffey, M J, Dickson, R C, Caldwell, S H, Stevenson, W S, Pruett, T L

Get more information

Successful retransplantation for recurrent posttransplant hepatitis B virus infection in the primary allograft by Ishitani, M, McGory, R, Dickson, R, Caldwell, S, Bickston, S, McCullough, C, Pruett, T

Get more information

Hemodynamic effects of rapid vancomycin infusion in critically ill patients by STIER, G. R, MCGORY, R. W, SPOTNITZ, W. D, SCHWENZER, K. J

“…The rapid infusion of vancomycin produces histamine release resulting in rash ("red-man's" syndrome) and hypotension. Because this phenomenon has been…”
Get full text

Significance of isolated pretransplant hepatitis B anticore antibody by Caldwell, S.H., Ishitani, M.B., Gaffey, M.J., Shepard, B.L., McGory, R., Pruett, T.L.

Get full text

Effects of fialuridine on hepatitis B immune globulin pharmacokinetics following orthotopic liver transplant for chronic hepatitis B viral-induced cirrhosis by McGory, R W, Ishitani, M B, Oliveira, W M, Stevenson, W C, Dickson, R C, Caldwell, S H, Pruett, T L

Get more information

Liver transplantation for hepatitis B cirrhosis: clinical sequela of passive immunization by al-Hemsi, B, McGory, R W, Shepard, B, Ishitani, M B, Stevenson, W C, McCullough, C, Pruett, T L

“…Aggressive administration of hepatitis B immune globulin (HBIg) has been shown to prevent hepatitis B viral (HBV) infection of the allograft; however, the…”
Get more information

Pharmacoeconomic analysis of HBV liver transplant therapies: Advances in the Treatment of Recurrent Hepatitis B After Liver Transplantation by MCGORY, R

Get full text

Hepatitis B immune globulin : the US experience: Advances in the Treatment of Recurrent Hepatitis B After Liver Transplantation by PRUETT, T. L, MCGORY, R

Get full text

URINARY MAGNESIUM LOSSES IN CRITICALLY ILL PATIENTS by Hamill, R., McGory, R.

Get full text